arrow
J

Jean Sibilia

centre de référence des maladies auto-immunes systémiques rares reso
H指数:94
被引数:3.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

CAR T-cell therapy in autoimmune diseases: where are we and where are we going?

CAR T-cell疗法在自身免疫性疾病中的应用:我们现在在哪里,我们将走向何方?

2025-03-260
PRE
Clinical spectrum and outcome of Takayasu's arteritis in children
2024-09-012
OAAI
EULAR/ACR 2017 CLASSIFICATION CRITERIA UNDERESTIMATE THE INCIDENCE OF INFLAMMATORY MYOPATHIES DUE TO THE IGNORANCE OF ANTISYNTHETASE SYNDROME AND SCLEROMYOSITIS: DATA FROM A QUADRUPLE SOURCES CAPTURE-RECAPTURE STUDY

EULAR/ACR 2017分类标准由于忽视了抗合成酶综合征和硬皮病肌炎,低估了炎症性肌病的发病率:四源捕获-再捕获研究的数据

2024-06-010
PRE
Refining Incidence and Characteristics of Inflammatory Myopathies: A Quadruple-Source Capture-Recapture Survey Using the 2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria
2023-08-044
OAAI
Association Between Bruton's Tyrosine Kinase Gene Overexpression and Risk of Lymphoma in Primary Sjogren's Syndrome

布鲁顿酪氨酸激酶基因过表达与原发性干燥综合征淋巴瘤发病风险的关系

2023-07-284
OAAI
Variability of Primary Sjogren's Syndrome Is Driven by Interferon α and Interferon α Blood Levels Are Associated With the Class II HLA-DQ Locus
2022-11-0225
OA
A Risk Score to Detect Subclinical Rheumatoid Arthritis-Associated Interstitial Lung Disease

用于检测亚临床类风湿关节炎相关间质性肺疾病的风险评分

2022-10-0541
OA
Different anti-SARS-CoV-2 vaccine response under B- and T-cell targeted therapies versus anti-cytokine therapies in patients with inflammatory arthritides
2022-10-011
OAAI